CRYSTALLINE FORMS
    1.
    发明公开
    CRYSTALLINE FORMS 审中-公开

    公开(公告)号:EP3981774A1

    公开(公告)日:2022-04-13

    申请号:EP21206477.8

    申请日:2017-09-21

    摘要: The invention relates to crystalline forms of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline forms, pharmaceutical compositions prepared from such crystalline forms and their use as a medicament, especially as a P2Y 12 receptor antagonist.